Literature DB >> 16163738

Location, location, location: the role of cyclin D1 nuclear localization in cancer.

Andrew B Gladden1, J Alan Diehl.   

Abstract

The control of cell proliferation is crucial in maintaining cellular homeostasis and loss of this mechanism is a principle hallmark of cancer cells. A primary target of growth factor signaling is the cyclin D1-dependent kinase (D1-CDK4/6) whose activity promotes G1 phase progression by phosphorylating the retinoblastoma protein (Rb) along with related pocket proteins 107 and p130, relieving inhibition of E2F family transcription factors. Cyclin D1 accumulation is regulated at multiple levels including transcription, post-translational activation and cellular localization throughout the cell cycle. While overexpression of cyclin D1 has been observed in a number of human cancers, mouse cancer models overexpressing D1 have fallen short of establishing a role for cyclin D1 in the initiation of malignant phenotypes suggesting an additional regulatory mechanism exists that prevents cyclin D1-driven cancer. This article will present an overview of current data investigating the regulation of cyclin D1 nuclear localization and the prevalence of these aberrations in cancer. Finally, future avenues of research involving cyclin D1 cellular localization and its regulation in cancer will be addressed. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163738     DOI: 10.1002/jcb.20613

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  55 in total

1.  Learning cellular sorting pathways using protein interactions and sequence motifs.

Authors:  Tien-Ho Lin; Ziv Bar-Joseph; Robert F Murphy
Journal:  J Comput Biol       Date:  2011-10-14       Impact factor: 1.479

2.  Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.

Authors:  Pascal Gelebart; Zoulika Zak; Jennifer Dien-Bard; Mona Anand; Raymond Lai
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

3.  Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival.

Authors:  Kazunori Mori; Etsuko Hirao; Yosuke Toya; Yukiko Oshima; Fumihiro Ishikawa; Kiyoshi Nose; Motoko Shibanuma
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

4.  Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.

Authors:  Youn-Tae Kwak; Sofyan M Radaideh; Lianghao Ding; Rui Li; Eugene Frenkel; Michael D Story; Luc Girard; John Minna; Udit N Verma
Journal:  Mol Cancer Res       Date:  2011-02-11       Impact factor: 5.852

5.  EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer.

Authors:  Du Wenqi; Wang Li; Cao Shanshan; Chen Bei; Zhang Yafei; Bai Feihu; Liu Jie; Fan Daiming
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

Review 6.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

7.  Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Wendy R Kam; Juan Ding; Mark P Hatton; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

8.  Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer.

Authors:  Meili Hao; Xiangmei Chen; Ting Zhang; Tao Shen; Qing Xie; Xiujuan Xing; Hongxi Gu; Fengmin Lu
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

9.  Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle.

Authors:  Rocio Tapia; Miriam Huerta; Socorro Islas; Antonia Avila-Flores; Esther Lopez-Bayghen; Jörg Weiske; Otmar Huber; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

10.  Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells.

Authors:  Tao Dao; Tatyana Korontsvit; Victoria Zakhaleva; Kurtis Haro; Jonathan Packin; David A Scheinberg
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.